Skip to main content

and
  1. Article

    Open Access

    Author Correction: Immunofluorescence can assess the efficacy of mTOR pathway therapeutic agent Everolimus in breast cancer models

    An amendment to this paper has been published and can be accessed via a link at the top of the paper.

    Chun-Ting Kuo, Chen-Lin Chen, Chih-Chi Li, Guan-Syuan Huang in Scientific Reports (2020)

  2. Article

    Open Access

    Immunofluorescence can assess the efficacy of mTOR pathway therapeutic agent Everolimus in breast cancer models

    When breast cancer patients start to exhibit resistance to hormonal therapy or chemotherapy, the mTOR inhibitor everolimus can be considered as an alternative therapeutic agent. Everolimus can deregulate the P...

    Chun-Ting Kuo, Chen-Lin Chen, Chih-Chi Li, Guan-Syuan Huang in Scientific Reports (2019)

  3. Article

    Open Access

    A Novel 96well-formatted Micro-gap Plate Enabling Drug Response Profiling on Primary Tumour Samples

    Drug-based treatments are the most widely used interventions for cancer management. Personalized drug response profiling remains inherently challenging with low cell count harvested from tumour sample. We pres...

    Wei-Yuan Ma, Lo-Chang Hsiung, Chen-Ho Wang, Chi-Ling Chiang in Scientific Reports (2015)